Prelude Therapeutics Inc (PRLD): Weighted Average Diluted Shares
76.96M
Year ended 2025-12-31
+17.6%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 76.96M | +1.5% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | 75.81M | +25.6% | 2026-03-10, From 2024-01-01 |
| 2023-12-31 | 60.36M | +27.4% | 2025-03-10, From 2023-01-01 |
| 2022-12-31 | 47.37M | +2.9% | 2024-02-15, From 2022-01-01 |
| 2021-12-31 | 46.05M | n/a | 2023-03-15, From 2021-01-01 |